Classic psychedelic research is rapidly expanding...
Volume 39, Issue 9 Psychedelics Supplement
In a well-blinded study, researchers investigated and directly compared the acute effects of LSD and psilocybin in healthy participants.
How can a robust understanding of the altered-state experience drive the development of therapeutic frameworks that are designed around that experience?
Numinus' Chief Clinical Officer shares resources about the potential use of ketamine in psychiatry.
Advertisement
Advertisement
Trending on Psychiatric Times
1
Lecanemab or Lithium? Compare Benefits, Risks, and Dose
2
FDA Clears Investigational New Drug Application for TNX-102 SL for Treatment of Major Depressive Disorder
3
Use of TMS in Treatment of Depression, Discussion With Rachel Rohaidy, MD
4
The Epstein Files, the Abuse of Women, and Psychiatry
5
